" /> Lacutamab - CISMeF





Preferred Label : Lacutamab;

NCIt synonyms : Anti-KIR3DL2 mAb IPH4102;

NCIt related terms : Anti-KIR3DL2 Monoclonal Antibody IPH4102;

NCIt definition : A humanized monoclonal antibody against the immune receptor human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), with potential immunomodulating and antineoplastic activities. Upon administration, lacutamab binds to KIR3DL2 expressed on certain tumor cells. This recruits natural killer (NK) cells and leads to lysis of KIR3DL2-expressing tumor cells. In addition, IPH4102 induces antibody-dependent cellular cytotoxicity (ADCC), thereby further eliminating tumor cells. KIR3DL2, a tumor-associated antigen (TAA) and inhibitory receptor of the KIR family, is specifically expressed in most subtypes of cutaneous T-cell lymphomas (CTCL) and expressed only on a fraction of normal NK cells.;

UNII : N8O7MY0VNS;

CAS number : 2187368-16-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2187368-16-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : IPH-4102;

NCI Metathesaurus CUI : CL503845;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.